Changes on the Board of Management and Supervisory Board of Sanochemia Pharmazeutika AG
Sanochemia Pharmazeutika AG announced changes in terms of the management of Sanochemia Pharmazeutika AG for urgent medical reasons pertaining to the former CEO/CFO Herbert Frantsits.
With immediate effect, Werner Frantsits, founder, former CEO and long-standing Chairman of the Supervisory Board, has taken up the position of CEO on an interim basis for the next nine months. The role of Chairman of the Supervisory Board for this period will be assumed by Günter Kahler, long-term General Manager of Forschungsförderungsfonds der Gewerblichen Wirtschaft and for a number of years a member of the Supervisory Board of Sanochemia. After this interim period, Werner Frantsits will reassume the position of Chairman of the Supervisory Board. Until further notice, the area of finances will be overseen by Christoph Stein who has supported the Company as a consultant in this field for the past two years.
Most read news
Organizations
Other news from the department people
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.